Dauntless Investment Group’s CervoMed CRVO Stock Holding History

Dauntless Investment Group’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$8	–	74
2025 Q4	$8	Buy	+1	New	+$8	﹤0.01%	65

Other funds holding CRVO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dauntless Investment Group's CRVO Position: Q1 2026 in Review

Dauntless Investment Group sold out of CervoMed (CRVO) in Q1 2026, closing a stake of 1 share — an estimated $8 sold.

Dauntless Investment Group first reported a position in CRVO in Q4 2025 and held it in 1 quarter. The position peaked at $8 in Q4 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

Dauntless Investment Group reported no remaining CervoMed position as of Q1 2026 after selling out during the quarter.
Dauntless Investment Group sold 1 CervoMed share in Q1 2026, an estimated $8.
Dauntless Investment Group first reported a position in CervoMed in Q4 2025 and held it in 1 quarter.
Dauntless Investment Group's CervoMed position peaked at $8 in Q4 2025.
36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.